Joshua Schiff, MD

Assistant Professor of Clinical Radiation Oncology

Image of Joshua Schiff, MD
Is this your profile? Click to edit

Overview

Dr. Joshua P. Schiff is an Assistant Professor of Clinical Radiation Oncology at the Keck School of Medicine. He joined the faculty in the fall of 2024. His clinical practice is primarily at the Pasadena Medical Office Building and the Norris Comprehensive Cancer Center. He grew up in Los Angeles in the San Fernando Valley, and graduated from the University of California, Santa Barbara with a bachelor’s degree in Biopsychology. He earned his medical doctorate degree at the Tulane University School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his residency at the Washington University School of Medicine in St. Louis, where he was chief resident. Dr. Schiff specializes in the treatment of a variety of cancer types using advanced radiotherapy delivery methods. His primary clinical focuses include gastrointestinal, thoracic, and breast cancers as well as benign conditions such as osteoarthritis. He has extensive experience with modern treatment techniques including intensity-modulated radiation therapy, volumetric-modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and motion management techniques. He has obtained funding for and opened multiple clinical trials with a focus on the implementation of new technology to improve treatment outcomes for patients, having previously focused on online adaptive radiotherapy, and now focusing on biology-guided radiotherapy. His work has resulted in numerous publications, presentations at national meetings, and awards, including the Roentgen Resident/Fellow Research award from the Radiological Society of North America.

Awards

  • Keck Medicine of USC: ESTRO Annual Conference Top Scoring Abstract, 2025
  • Keck Medicine of USC: Certificate of Academic Achievement, Department of Radiology, 2024
  • Washington University School of Medicine: Roentgen Resident Research Award, 2024
  • Tulane University School of Medicine: Alpha Omega Alpha, 2019

Education and Training

  • Washington University School of Medicine in St. Louis, St. Louis, MO — 06/2024 — Residency – Radiation Oncology
  • Cedars Sinai Medical Center, Los Angeles, CA — 06/2020 — Internship – Internal Medicine
  • Tulane University School of Medicine, New Orleans, LA — MD — 05/2019
  • University of California, Santa Barbara, Santa Barbara, CA — BS — 06/2014

Publications

  • Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy. Cureus. 2024 Aug; 16(8):e66218.. View in PubMed
  • Feasibility of simulation free abdominal stereotactic adaptive radiotherapy using an expedited pre-plan workflow. Phys Imaging Radiat Oncol. 2024 Jul; 31:100611.. View in PubMed
  • The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR). Cureus. 2024 Jun; 16(6):e62906.. View in PubMed
  • The impact of an Advanced Practice Radiation Therapist contouring for a CBCT-based adaptive radiotherapy program. Tech Innov Patient Support Radiat Oncol. 2024 Jun; 30:100242.. View in PubMed
  • Feasibility of surface-guidance combined with CBCT for intra-fractional breath-hold motion management during Ethos RT. J Appl Clin Med Phys. 2024 Apr; 25(4):e14242.. View in PubMed
  • The Use of MR-Guided Radiation Therapy for Liver Cancer. Semin Radiat Oncol. 2024 01; 34(1):36-44.. View in PubMed
  • A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2024 Jan; 44:100692.. View in PubMed
  • Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program. Clin Transl Radiat Oncol. 2023 Sep; 42:100661.. View in PubMed
  • Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience. Clin Transl Radiat Oncol. 2023 Jul; 41:100627.. View in PubMed
  • Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease. Adv Radiat Oncol. 2023 Nov-Dec; 8(6):101226.. View in PubMed